This study was designed to detect the therapeutic effects of galbanum oil plus dry cupping (a Persian medicine-based method) in hospitalized patients with coronavirus disease-2019 (COVID-19).

Galbanum oil is composed of monoterpenes in large amounts and pyrazines in small amounts. Although the monoterpenes are the main components of galbanum oil, they hardly contribute to the distinct galbanum aroma. The scanty amounts of pyrazines, in contrast, contribute significantly to the aroma. Considering the complexity and potency of the odor, the essential oil was assumed to contain so far not identified compounds with high odor contribution. By the gas chromatography-mass spectrometry-olfactometry (GC-MS-O) analysis of galbanum oil, fruity-green-balsamic notes were detected at two different retention times. The mass spectra (MS) of the newly discovered notes were elucidated by conducting multidimensional (MD) GC-MS-O. By analyzing the MS data, six chemical structures were proposed: (6E/Z,8E)-undeca-6,8,10-trien-2-one, (6E/Z,8E)-undeca-6,8,10-trien-3-one, and (6E/Z,8E)-undeca-6,8,10-trien-4-one. The compounds were then synthesized in an attempt to match the MS, retention indices (RI), and odor qualities. The MD-GC-MS-O analyses of the candidate compounds led to the identification of the novel key aroma compounds (6Z,8E)-undeca-6,8,10-trien-3-one and (6Z,8E)-undeca-6,8,10-trien-4-one in galbanum oil.

Following an analysis of available SAR data on green/galbanum-smelling molecules, a series of new 2-substituted hepta-1,6-dien-3-ones and their analogues were prepared and their olfactory properties evaluated. The study allowed to select efficient new odourants-potential substitutes for natural galbanum oil-and to generate an olfactophore model for the green/galbanum note.